Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific Antibodies - Top-Institutions - MDSpire

Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific Antibodies

  • By

  • Idoia Bilbao

  • María Ansón

  • Sara Villar

  • Iñigo Pineda

  • Laura Gárriz

  • Manuel Pina-Sánchez

  • Luis-Esteban Tamariz-Amador

  • Paula Rodríguez-Otero

  • José Ramón Yuste

  • José L del Pozo

  • November 4, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Immunotherapy
    • Infectious Diseases

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Immunotherapy
    • Infectious Diseases

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology-Oncology
    • Immunotherapy
    • Infectious Diseases

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology-Oncology
    • Immunotherapy
    • Infectious Diseases

Original Source(s)

Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific Antibodies

  • by Idoia Bilbao, María Ansón, Sara Villar, Iñigo Pineda, Laura Gárriz, Manuel Pina-Sánchez, Luis-Esteban Tamariz-Amador, Paula Rodríguez-Otero, José Ramón Yuste, José L del Pozo

  • November 4, 2025

Related Content

Improving outcomes with anti-BCMA bispecific antibodies with attention to infection

Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma

Not all plasma cells are made equal: well-hidden layers of heterogeneity